Seller record · Telehealth service

Trillium Meds

By Paul Harris, Standards EditorRecorded September 2026 · Standard v1.1 · How checks are performed

Fails 1 of 8 criteria. S5, analytical documentation: No certificate of analysis or lot document is published on the pricing page, the compounding page or the terms.

At a glance

Trillium MedsTelehealth service

7/8criteria passed

Price: Compounded tirzepatide from $199 for a one-month plan at any dose; plans as low as $86 a month
Sells: compounded tirzepatide, compounded semaglutide
FDA letters: None on file

Visit Trillium Meds See all eight dispositions

Telehealth service. Passes 7 of 8 criteria. Recorded against Standard v1.1.

A subscription telehealth service that lets a buyer compare named compounding pharmacies' plan prices for tirzepatide and semaglutide before starting, with care from independent licensed providers after an online health intake. It serves all 50 states and Puerto Rico.

Operating entity Trillium Meds LLC

Dispositions

Code	Criterion	Disposition	Where it appears
S1	Prescriber requirement	PASS	Trillium Meds' website; Trillium Meds' terms
S2	Prescription gating	PASS	Trillium Meds' website; Trillium Meds' terms
S3	Pharmacy identification	PASS	Trillium Meds' weight management page
S4	Compounding disclosure	PASS	Trillium Meds' weight management page; Trillium Meds' compounding page; Trillium Meds' website
S5	Analytical documentation	FAIL	Trillium Meds' weight management page; Trillium Meds' compounding page; Trillium Meds' terms
S6	Business address	PASS	Trillium Meds' website; Trillium Meds' terms; Trillium Meds' refund page
S7	Price disclosure	PASS	Trillium Meds' weight management page; Trillium Meds' website
S8	Enforcement status	PASS	FDA warning-letter index

Evidence, criterion by criterion

The evidence behind each disposition in the table above, where it appears, and its date.

S1PASSAn independent licensed provider reviews each health intake and decides whether a prescription is appropriate, and the site says it is not a medical provider and that care decisions rest with those providers. No provider is named.Source: Trillium Meds' website; Trillium Meds' terms.

S2PASSThe steps are a secure health intake, then a provider's review, then a prescription decision, then pharmacy fulfillment. The terms say some payments are held as a temporary authorization pending the provider's review and released if treatment is not prescribed.Source: Trillium Meds' website; Trillium Meds' terms.

S3PASSThe pricing page names the pharmacies whose offers a buyer chooses between: Hyalo Technologies Pharmacy, whose offer names NewLife Pharmacy as the fulfillment pharmacy, Nova Specialty Pharmacy, Hallandale Pharmacy and Drug Crafters Pharmacy, with Southend Pharmacy listed as coming soon.Source: Trillium Meds' weight management page.

S4PASSThe pricing page carries a compounded medication notice stating that compounded medications are not FDA-approved and are not reviewed by the FDA, and the footer and the compounding page repeat it.Source: Trillium Meds' weight management page; Trillium Meds' compounding page; Trillium Meds' website.

S5FAILNo certificate of analysis or lot document is published on the pricing page, the compounding page or the terms.Source: Trillium Meds' weight management page; Trillium Meds' compounding page; Trillium Meds' terms.

S6PASSTrillium Meds LLC at 5441 S Macadam Ave Ste N, Portland, OR 97239, printed in the footer of every page and in the terms, refund and shipping policies. The terms name Oregon law.Source: Trillium Meds' website; Trillium Meds' terms; Trillium Meds' refund page.

S7PASSThe pricing page prints each pharmacy's plan totals before any intake. The Hyalo Technologies Pharmacy tirzepatide offer costs $199 for a one-month plan at any dose, $399 for a 3-month starter plan for people new to GLP-1s and $499 for a 3-month plan at any dose. The home page says plans cost as low as $86 a month, with no membership fee.Source: Trillium Meds' weight management page; Trillium Meds' website.

S8PASSNo FDA warning letter names Trillium Meds or Trillium Meds LLC, and no action has halted the business.Source: FDA warning-letter index.

Products shown on the seller's own pages at the recorded date: compounded tirzepatide, compounded semaglutide.

Other sellers of the same products

Who sells semaglutide Who sells tirzepatide

Visit Trillium Meds

Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.